Drug Shortage Report for NASONEX
Report ID | 70041 |
Drug Identification Number | 02238465 |
Brand name | NASONEX |
Common or Proper name | mometasone furoate monohydrate aqueous nasal spray |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | MOMETASONE FUROATE |
Strength(s) | 50MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 140dose |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-12-19 |
Estimated end date | 2019-01-05 |
Actual end date | 2018-12-21 |
Shortage status | Resolved |
Updated date | 2018-12-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-12-22 | English | Compare |
v5 | 2018-12-21 | French | Compare |
v4 | 2018-12-21 | English | Compare |
v3 | 2018-12-20 | English | Compare |
v2 | 2018-12-19 | French | Compare |
v1 | 2018-12-19 | English | Compare |
Showing 1 to 6 of 6